{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:12:49Z","timestamp":1791598369890,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Hintergrund<\/jats:title>\n                    <jats:p>Long\/Post-COVID und ME\/CFS gehen h\u00e4ufig mit Fatigue, kognitiven St\u00f6rungen und psychischen Symptomen einher. Die psychiatrisch-psychotherapeutische Versorgung ist durch unklare Evidenzlagen, symptomatische \u00dcberschneidungen und kontroverse Therapieempfehlungen herausgefordert.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ziel<\/jats:title>\n                    <jats:p>Darstellung und Vergleich psychiatrischer und psychotherapeutischer Empfehlungen in relevanten internationalen und nationalen Leitlinien zu Long\/Post-COVID und ME\/CFS mit Fokus auf Psychotherapie und Psychopharmakotherapie.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methoden<\/jats:title>\n                    <jats:p>Es wurde ein narratives Review durchgef\u00fchrt. Ber\u00fccksichtigt wurden nationale und internationale Leitlinien mit Fokus auf ME\/CFS und Long\/Post-COVID, publiziert zwischen 2020 und 2025, insbesondere von WHO, AWMF, NICE, CDC und IQWiG. Die ausgew\u00e4hlten Leitlinien wurden inhaltlich zu zentralen Aspekten analysiert.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ergebnisse<\/jats:title>\n                    <jats:p>Psychiatrische Pharmakotherapie wird nur bei komorbiden Erkrankungen empfohlen. Psychotherapeutische Ma\u00dfnahmen werden in den Leitlinien \u00fcberwiegend als unterst\u00fctzend empfohlen. Aktivierende Behandlungsans\u00e4tze wie \u201egraded exercise therapy\u201c (GET) werden in Verbindung mit postexertionaler Malaise (PEM) \u00fcberwiegend kritisch bewertet, w\u00e4hrend f\u00fcr Patientinnen und Patienten ohne PEM in mehreren Leitlinien moderate, individuell adaptierte Aktivierung ausdr\u00fccklich bef\u00fcrwortet wird. Pacing-Strategien werden leitlinien\u00fcbergreifend als zentrales Konzept der Aktivit\u00e4tssteuerung hervorgehoben.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diskussion<\/jats:title>\n                    <jats:p>Psychiatrisch-psychotherapeutische Interventionen sind bei Long COVID und ME\/CFS unterst\u00fctzend, aber keine kausale Therapie. Leitlinien empfehlen symptomorientierte, individualisierte Therapieans\u00e4tze sowie eine integrative Betrachtung somatischer, sozialer und psychischer Einflussfaktoren im Sinne des biopsychosozialen Modells. Es besteht ein hoher Bedarf an spezifischer Forschung zu psychotherapeutischen Interventionsformen in diesen Patientengruppen.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00115-026-01944-9","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:34:49Z","timestamp":1771860889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychiatrische und psychotherapeutische Empfehlungen bei Long\/Post-COVID und ME\/CFS: ein narratives Review internationaler Leitlinien","Psychiatric and psychotherapeutic recommendations for long\/post-COVID and ME\/CFS: a\u00a0narrative review of international guidelines"],"prefix":"10.1007","author":[{"given":"Gizem","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Kroehn-Liedtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Kalinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Kenneth","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adak","family":"Pirmorady-Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Dini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryam","family":"Schouler-Ocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"1944_CR1","unstructured":"Deutsche Gesellschaft f\u00fcr ME\/CFS. (2024). Long COVID. https:\/\/www.mecfs.de\/longcovid\/"},{"key":"1944_CR2","unstructured":"American Psychological Association. (2025). Stichwort: ME\/CFS, Post Covid, PEM, PAIS. Verf\u00fcgbar unter: https:\/\/science.apa.at\/power-search\/13285531769625838666"},{"key":"1944_CR3","unstructured":"World Health Organization (2022) Clinical management of COVID-19: Living guideline. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2022-1"},{"key":"1944_CR4","unstructured":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2023) S3-Leitlinie M\u00fcdigkeit\/Postvirale Fatigue (AWMF-Register-Nr. 053-009). https:\/\/register.awmf.org\/de\/leitlinien\/detail\/053-002"},{"issue":"11","key":"1944_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1055\/a-1551-9734","volume":"75","author":"AR Koczulla","year":"2021","unstructured":"Koczulla\u00a0AR et\u00a0al (2021) S1 Guideline Post-COVID\/Long-COVID. Pneumologie 75(11):869\u2013900. https:\/\/doi.org\/10.1055\/a-1551-9734","journal-title":"Pneumologie"},{"key":"1944_CR6","unstructured":"Centers for Disease Control and Prevention. (2023). ME\/CFS (Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome) Guidelines. https:\/\/www.cdc.gov\/me-cfs\/"},{"key":"1944_CR7","unstructured":"Deutsche Gesellschaft f\u00fcr ME\/CFS (2024) Post-Exertional Malaise (PEM). https:\/\/www.mecfs.de\/was-ist-me-cfs\/pem\/"},{"key":"1944_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2025.1495050","author":"M Vink","year":"2025","unstructured":"Vink\u00a0M, Vink-Niese\u00a0A (2025) CBT and graded exercise therapy studies have proven that ME\/CFS and long COVID are physical diseases, yet no one is aware of that. Front Hum Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2025.1495050","journal-title":"Frontiers in Human Neuroscience"},{"key":"1944_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.zefq.2025.03.005","author":"K Vieth","year":"2025","unstructured":"Vieth\u00a0K, Roder\u00a0S, M\u00fcller\u00a0F, Wegener\u00a0GS, M\u00fcllenmeister\u00a0C, El-Sayed\u00a0I, K\u00f6nigs\u00a0G, Schr\u00f6der\u00a0D, Schmachtenberg\u00a0T (2025) Wie gehen Menschen mit Long COVID mit ihren Symptomen und Alltagseinschr\u00e4nkungen um? Eine qualitative Studie mit vier Fokusgruppen. Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ). https:\/\/doi.org\/10.1016\/j.zefq.2025.03.005","journal-title":"Z. Evid. Fortbild. Qual. Gesundh. wesen (ZEFQ)"},{"issue":"4","key":"1944_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/02813432.2023.2235609","volume":"41","author":"TN Alme","year":"2023","unstructured":"Alme\u00a0TN, Andreasson\u00a0A, Asprusten\u00a0TT et\u00a0al (2023) Chronic fatigue syndromes: Real illnesses that people can recover from. Scand J Prim Health Care 41(4):372\u2013376. https:\/\/doi.org\/10.1080\/02813432.2023.2235609","journal-title":"Scandinavian Journal of Primary Health Care"},{"issue":"3","key":"1944_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s11136-024-03854-2","volume":"34","author":"Z Sirotiak","year":"2025","unstructured":"Sirotiak\u00a0Z, Adamowicz\u00a0JL, Thomas\u00a0EBK (2025) Depressive and anxiety symptoms in current, previous, and no history of ME\/CFS: NHIS 2022 analysis. Qual Life Res 34(3):777\u2013787. https:\/\/doi.org\/10.1007\/s11136-024-03854-2","journal-title":"Quality of Life Research"},{"key":"1944_CR12","doi-asserted-by":"publisher","unstructured":"Caswell A, Daniels J (2018) Anxiety and depression in Chronic Fatigue Syndrome: Prevalence and effect on treatment. A systematic review, meta-analysis and meta-regression. Conference: British Association of Behavioural and Cognitive Psychotherapy, Glasgow. https:\/\/doi.org\/10.13140\/RG.2.2.12151.27043","DOI":"10.13140\/RG.2.2.12151.27043"},{"issue":"3","key":"1944_CR13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36886","volume":"15","author":"S Shaikh","year":"2023","unstructured":"Shaikh\u00a0S et\u00a0al (2023) COVID-19: Post-recovery Manifestations. Cureus 15(3):e36886. https:\/\/doi.org\/10.7759\/cureus.36886","journal-title":"Cureus"},{"key":"1944_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/21641846.2022.2154500","author":"E Bautista Rodriguez","year":"2022","unstructured":"Bautista Rodriguez\u00a0E et\u00a0al (2022) Stress, anxiety, depression and long COVID symptoms. Fatigue. https:\/\/doi.org\/10.1080\/21641846.2022.2154500","journal-title":"Fatigue: Biomedicine, Health & Behavior"},{"issue":"4","key":"1944_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00761-022-01102-1","volume":"28","author":"B Buchberger","year":"2022","unstructured":"Buchberger\u00a0B, Zwierlein\u00a0R, Rohde\u00a0V (2022) Post-Corona-Fatigue \u2013 das bekannte Bild in neuem Gewand? Onkologie 28(4):340\u2013346. https:\/\/doi.org\/10.1007\/s00761-022-01102-1","journal-title":"Der Onkologe"},{"key":"1944_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2025.112048","volume":"190","author":"M Schurr","year":"2025","unstructured":"Schurr\u00a0M et\u00a0al (2025) Psychotherapy in patients with long\/post-COVID: A systematic review on the feasibility, acceptability, safety, and efficacy of available and emerging interventions. Journal of Psychosomatic Research 190:112048. https:\/\/doi.org\/10.1016\/j.jpsychores.2025.112048","journal-title":"Journal of Psychosomatic Research"},{"issue":"3","key":"1944_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1017\/S0033291723003148","volume":"54","author":"TA Kuut","year":"2024","unstructured":"Kuut\u00a0TA et\u00a0al (2024) Does the effect of cognitive behavior therapy for chronic fatigue syndrome (ME\/CFS) vary by patient characteristics? A systematic review and individual patient data meta-analysis. J\u00a0Mil Gov Couns 54(3):447\u2013456. https:\/\/doi.org\/10.1017\/S0033291723003148","journal-title":"Psychological Medicine"},{"key":"1944_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040719","author":"T Grande","year":"2023","unstructured":"Grande\u00a0T et\u00a0al (2023) The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Medicina. https:\/\/doi.org\/10.3390\/medicina59040719","journal-title":"Medicina"},{"key":"1944_CR19","unstructured":"National Institute for Health and Care Excellence (2021) Myalgic encephalomyelitis (or encephalopathy)\/chronic fatigue syndrome: diagnosis and management (NG206). https:\/\/www.nice.org.uk\/guidance\/ng206"},{"key":"1944_CR20","doi-asserted-by":"crossref","unstructured":"Bisenius, S., & Kersting, A. (2022). Psychosomatische Aspekte von Long-Covid: \u00dcberblick zum Stand der Forschung. Fortschritte der Medizin, 164(1). Verf\u00fcgbar unter: https:\/\/www.springermedizin.de\/posttraumatische-belastungsstoerung\/covid-19\/psychosomatische-aspekte-von-long-covid\/20048738","DOI":"10.1007\/s15006-021-0540-1"},{"key":"1944_CR21","unstructured":"Bundesministerium f\u00fcr Gesundheit (2024) ME\/CFS: aktueller Kenntnisstand \u2013 Abschlussbericht. https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Abschlussberichte\/ME-CFS-aktueller-Kenntnisstand_Abschlussbericht_V1-0.pdf"},{"key":"1944_CR22","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (2023) Abschlussbericht: ME\/CFS \u2013 Diagnostik, Therapie und Versorgung. https:\/\/www.iqwig.de\/download\/n21-01_me-cfs-aktueller-kenntnisstand_abschlussbericht_v1-0.pdf"},{"key":"1944_CR23","unstructured":"NICE Evidence Reviews Collection. (2020). COVID-19 rapid guideline: Managing the long-term effects of COVID-19 (NG188): Evidence review 5: Interventions. National Institute for Health and Care Excellence. Verf\u00fcgbar unter: https:\/\/www.nice.org.uk\/guidance\/ng188"},{"key":"1944_CR24","unstructured":"Centers for Disease Control and Prevention. (2025). Guidance for Evaluating and Managing Long COVID. https:\/\/www.cdc.gov\/long-covid\/hcp\/clinical-guidance\/index.html"},{"key":"1944_CR25","unstructured":"National Institute for Health and Care Excellence (2025) COVID-19 rapid guideline: Managing COVID-19. https:\/\/www.nice.org.uk\/guidance\/ng191"},{"issue":"5","key":"1944_CR26","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.clinthera.2019.02.011","volume":"41","author":"S Richman","year":"2019","unstructured":"Richman\u00a0S et\u00a0al (2019) Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary. Clin Ther 41(5):798\u2013805. https:\/\/doi.org\/10.1016\/j.clinthera.2019.02.011","journal-title":"Clinical Therapeutics"},{"key":"1944_CR27","unstructured":"Reid, S. F., et al. (2008). Chronic fatigue syndrome. BMJ Clinical Evidence, 2008.\nVerf\u00fcgbar unter: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2907931\/"},{"issue":"9005","key":"1944_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/s0140-6736(96)91345-8","volume":"347","author":"JH Vercoulen","year":"1996","unstructured":"Vercoulen\u00a0JH et\u00a0al (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347(9005):858\u2013861. https:\/\/doi.org\/10.1016\/s0140-6736(96)91345-8","journal-title":"The Lancet"},{"issue":"6","key":"1944_CR29","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1055\/a-2374-2218","volume":"92","author":"U Bonnet","year":"2024","unstructured":"Bonnet\u00a0U, Juckel\u00a0G (2024) Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID \u2013 Ein Scoping-Review Update. Fortschritte der Neurologie \u2013 Psychiatrie 92(6):345\u2013352. https:\/\/doi.org\/10.1055\/a-2374-2218","journal-title":"Fortschritte der Neurologie \u2013 Psychiatrie"},{"key":"1944_CR30","unstructured":"World Health Organization. (2023). Living guidance for clinical management of COVID-19. World Health Organization. Verf\u00fcgbar unter: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.2"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-026-01944-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-026-01944-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:02:51Z","timestamp":1781820171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-026-01944-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":30,"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1007\/s00115-026-01944-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Schouler-Ocak, A.\u00a0Pirmorady-Sehouli, G.\u00a0Kaya, F.\u00a0Kroehn-Liedtke, O.\u00a0Kalinowski, L.\u00a0Dini, R.\u00a0Neal und J.K.\u00a0Moran sind im PAIS Care Berlin\u00a0\u2013 Projekt, einem Modellprojekte zur koordinierten Versorgung auf Grundlage der GBA-Richtlinie Long Covid, gef\u00f6rdert vom BMG, beteiligt.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}